All posts by: Michael Zand

Patents on CRISPR-related technology are going to become a lot … – IAM (blog)

IAM (blog)Patents on CRISPR-related technology are going to become a lot …IAM (blog)A life sciences patent expert is warning that obtaining CRISPR IP rights is set to become much more difficult. Improved knowledge of the…and more &raquo… Continue reading

Historic Cambridge biology lab spreads its wings – Business Weekly

Business WeeklyHistoric Cambridge biology lab spreads its wingsBusiness WeeklyIt is part of a global movement in community biotechnology and is particularly focused on synthetic biology, which has a range of commercial applications and is using the cut… Continue reading

Voyager’s gene therapy for Parkinson’s shows promise in early data from small Phase Ib trial – Endpoints News

Should patients with ALL undergo HSCT after CAR T-cell therapy? – Healio

Should patients with ALL undergo HSCT after CAR T-cell therapy?HealioCAR T-cell therapies for ALL hold great promise, yielding remission rates of up to 90% for relapsed/refractory patients. However, the durability of these responses remains uncertain, … Continue reading

Should patients with ALL undergo HSCT after CAR T-cell therapy? – Healio

Should patients with ALL undergo HSCT after CAR T-cell therapy?HealioCAR T-cell therapies for ALL hold great promise, yielding remission rates of up to 90% for relapsed/refractory patients. However, the durability of these responses remains uncertain, … Continue reading

CRISPR update calms fears about off-target editing effects – Genetic Literacy Project

Genetic Literacy ProjectCRISPR update calms fears about off-target editing effectsGenetic Literacy ProjectA study last year involving just three mice raised fears that CRISPR-Cas9, the classic version of the genome editor, might be a big, stupid bloodh… Continue reading